Abstract 1663: Discovery of novel, potent and orally bioavailable SMARCA2 PROTACs with synergistic anti-tumor activity in combination with KRAS G12C inhibitors
Authors: Yonathan Lissanu, Sasi Kotagiri, Nicholas Blazanin, Yawen Wang, Yanyan Han, Xiaobing Liang